Azooka, a biotech company, had achieved a fair degree of success by relying solelyon seed funding and grants. But as the company contemplated its future growth trajectory, it had to review its financing options. The case outlines three strategies that Azooka could adopt over the next 3-5 years. First, it could rely on bootstrap financing to grow the business gradually. Second, it could attempt an ambitious growth strategy with venture capital funding. Third, it could consider divestment opportunities for its main product, Tinto Rang, which would provide sufficient dry powder for the company to pursue other options in green chemistry.